Exposure of hemodialysis patients to di-2-ethylhexyl phthalate.
暂无分享,去创建一个
M. Luyckx | B. Gressier | T. Dine | K. Kambia | C. Brunet | D. Pagniez | J. Cazin | M. Cazin | M. A. Faouzi | A. Belabed
[1] T. Mettang,et al. Uraemic pruritus and exposure to di(2-ethylhexyl)phthalate (DEHP) in haemodialysis patients , 1996 .
[2] T. Mettang,et al. The Fate of Leached Di(2-Ethylhexyl)Phthalate in Patients Undergoing Capd Treatment , 1996, Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis.
[3] M. Luyckx,et al. Stability, compatibility and plasticizer extraction of miconazole injection added to infusion solutions and stored in PVC containers. , 1995, Journal of pharmaceutical and biomedical analysis.
[4] S. K. Kang,et al. A Comparative Study of Platelets Stored in Polyvinyl Chloride Containers Plasticised with Butyryl Trihexyl Citrate or Triethylhexyl Trimellitate , 1995, Vox sanguinis.
[5] T. Watanabe,et al. Enhancement by peroxisome proliferators of the susceptibility to DNA damage in the liver of male F344 rats. , 1995, Cancer letters.
[6] K. Knights,et al. Differential induction of rat hepatic microsomal and peroxisomal long-chain and nafenopin-CoA ligases by clofibric acid and di-(2-ethylhexyl)phthalate. , 1995, Xenobiotica; the fate of foreign compounds in biological systems.
[7] Z. Rácz,et al. Effect of DEHP Plasticizer on Stored Platelets , 1995, Vox sanguinis.
[8] M. Badr,et al. Mechanism of phthalate-induced inhibition of hepatic mitochondrial β-oxidation , 1995 .
[9] H. K. Bojes,et al. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo. , 1994, Toxicology and applied pharmacology.
[10] H. Nau,et al. Exposure of newborn infants to di‐(2‐ethylhexyl)‐phthalate and 2‐ ethylhexanoic acid following exchange transfusion with polyvinylchloride catheters , 1993, Transfusion.
[11] C. Elcombe,et al. In vitro inhibition of carnitine acyltransferase activity in mitochondria from rat and mouse liver by a diethylhexylphthalate metabolite. , 1993, Biochemical pharmacology.
[12] H. Dirven,et al. Metabolites of the plasticizer di (2-ethylhexyl) phthalate in urine samples of workers in polyvinylchloride processing industries , 1993, International archives of occupational and environmental health.
[13] H. Dirven,et al. Determination of four metabolites of the plasticizer di (2-ethylhexyl) phthalate in human urine samples , 1993, International archives of occupational and environmental health.
[14] J. Noordhoek,et al. Microsomal lauric acid hydroxylase activities after treatment of rats with three classical cytochrome P450 inducers and peroxisome proliferating compounds. , 1992, Biochemical pharmacology.
[15] J. Okita,et al. Characterization of a cytochrome P450 from di(2-ethylhexyl) phthalate-treated rats which hydroxylates fatty acids. , 1992, Archives of biochemistry and biophysics.
[16] A. Christensson,et al. In vivo Comparative Evaluation of Hemodialysis Tubing Plasticized with DEHP and TEHTM , 1991, The International journal of artificial organs.
[17] V. Stella,et al. Stability, compatibility, and plasticizer extraction of taxol (NSC-125973) injection diluted in infusion solutions and stored in various containers. , 1991, American journal of hospital pharmacy.
[18] M. Luyckx,et al. Rapid determination by high performance liquid chromatography of di-2-ethylhexyl phthalate in plasma stored in plastic bags. , 1991, Biomedical chromatography : BMC.
[19] J. Reddy. Carcinogenicity of peroxisome proliferators: evaluation and mechanisms. , 1990, Biochemical Society transactions.
[20] W. Keon,et al. Perioperative exposure to plasticizers in patients undergoing cardiopulmonary bypass. , 1989, The Journal of thoracic and cardiovascular surgery.
[21] R. Cattley,et al. Relationship of oxidative damage to the hepatocarcinogenicity of the peroxisome proliferators di(2-ethylhexyl)phthalate and Wy-14,643. , 1989, Carcinogenesis.
[22] R. Cattley,et al. Possible Mechanisms in Hepatocarcinogensis by the Peroxisome Proliferator Di(2-Ethylhexyl)Phthalate , 1989 .
[23] R. Bergia,et al. The fate of leached di-(2-ethylhexyl)-phthalate (DEHP) in patients on chronic haemodialysis. , 1988, The International journal of artificial organs.
[24] B. Lake,et al. Co-induction of microsomal cytochrome P-452 and the peroxisomal fatty acid beta-oxidation pathway in the rat by clofibrate and di-(2-ethylhexyl)phthalate. Dose-response studies. , 1988, Biochemical pharmacology.
[25] L. Nässberger,et al. Exposure of patients to phthalates from polyvinyl chloride tubes and bags during dialysis. , 1987, Nephron.
[26] C. Elcombe,et al. Peroxisome proliferation due to di(2-ethylhexyl) phthalate (DEHP): species differences and possible mechanisms. , 1986, Environmental health perspectives.
[27] C. S. Giam,et al. Leaching of diethylhexyl phthalate from polyvinyl chloride bags into intravenous cyclosporine solution. , 1986, American journal of hospital pharmacy.
[28] M. Allwood. The release of phthallate ester plasticizer from intravenous administration sets into fat emulsion , 1986 .
[29] S. Jacobsson,et al. Studies on contamination of intravenous solutions from PVC-bags with dynamic headspace GC-MS and LC-diode array techniques , 1986 .
[30] U. Bondesson,et al. Exposure of newborn infants to plasticizers: Plasma levels of di‐(2‐ ethylhexyl) phthalate and mono‐(2‐ethylhexyl) phthalate during exchange transfusion , 1985, Transfusion.
[31] D. Shen,et al. Circulating concentrations of di(2-ethylhexyl) phthalate and its de-esterified phthalic acid products following plasticizer exposure in patients receiving hemodialysis. , 1985, Toxicology and applied pharmacology.
[32] Y. Nakamura,et al. Teratogenicity/fetotoxicity of DEHP in mice. , 1982, Environmental health perspectives.
[33] J. F. Douglas,et al. The carcinogenicity of dietary di(2-ethylhexyl) phthalate (DEHP) in Fischer 344 rats and B6C3F1 mice. , 1982, Journal of toxicology and environmental health.
[34] S. Nakamoto,et al. Bis(2-ethylhexyl)phthalate concentrations in the serum of hemodialysis patients. , 1978, Clinical Chemistry.
[35] T. Gibson,et al. Delivery of di-2-ethylhexyl phthalate to patients during hemodialysis. , 1976, The Journal of laboratory and clinical medicine.